Page last updated: 2024-12-11

lithium borate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

lithium borate: RN given refers to cpd with MF of Li2-B4O7; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13743157
CHEBI ID38910
MeSH IDM0075501

Synonyms (11)

Synonym
trilithium borate
CHEBI:38910
li3bo3
lithium borate
12676-27-6
FT-0627892
RIUWBIIVUYSTCN-UHFFFAOYSA-N
DTXSID40926674
trilithium;borate
Q27118033
lithiumtetraborateanhydrous

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"To compare perioperative factors and adverse events (AEs) in men undergoing photoselective vaporisation of the prostate (PVP) with or without continued anticoagulation therapy."( Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180-W Greenlight lithium triborate laser.
Chalasani, V; Knapp, GL; Woo, HH, 2017
)
0.46

Dosage Studied

ExcerptRelevanceReference
" A good linear TL dose-response for β-particles was obtained in the dose range 66."( Dosimetric properties of lithium borate glass doped with dysprosium.
El-Faramawy, N; El-Kinawy, M; El-Naggar, A; Woda, C, 2021
)
0.62
" The activation energy (E) and frequency factor (s) were calculated for each peak shape parameter τ (low temperature half width), δ (high temperature half-width) and ω (total half width) using Chen's peak shape (PS) method and the order of kinetics was deduced from the symmetry factor (μg) and gamma dose-response curves."( THERMOLUMINESCENCE AND KINETIC PARAMETERS OF MICRO-NANO MATRIX OF LITHIUM TRIBORATE AND ZINC OXIDE NANOPARTICLE.
Ayoade Aborisade, C; Ayodele Oke, J; Samuel Ajayi, O; Samuel Oluyamo, S; Uche Ofiwe, C, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
borate salts
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (69)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (7.25)18.7374
1990's4 (5.80)18.2507
2000's14 (20.29)29.6817
2010's36 (52.17)24.3611
2020's10 (14.49)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.45%)5.53%
Reviews3 (4.35%)6.00%
Case Studies1 (1.45%)4.05%
Observational1 (1.45%)0.25%
Other63 (91.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]